Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
Open the sourceReported by Business Insider, businessinsider.com, 31 October 2026, by Tom Carter
50Impact 50 of 100, routine
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at businessinsider.com.
Named in this story
Isomorphic Labs, Google DeepMind, Max Jaderberg, AlphaFold, Demis Hassabis